Showing 221 - 240 results of 516 for search '"Cell therapy"', query time: 0.08s Refine Results
  1. 221

    MOUSE AND HUMAN EMBRYONIC STEM CELLS by A. G. Menzorov

    Published 2014-12-01
    “…Attention is given to some unresolved questions of ES cell biology and prospects of ES cells in cell therapy.…”
    Get full text
    Article
  2. 222
  3. 223
  4. 224

    Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma by Hui-Ju Hsieh, Ryan Urak, Mary C. Clark, Larry W. Kwak, Stephen J. Forman, Xiuli Wang

    Published 2025-03-01
    “…Since PTEN deficiency is common in cancer and is the main mechanism for capivasertib function, combination therapy may provide an alternative solution for the challenges of CAR T cell therapy.…”
    Get full text
    Article
  5. 225

    Advancements and Challenges in Immune Protection Strategies for Islet Transplantation by Xue Wang, Ziyuan Zeng, Dayan Li, Kai Wang, Wei Zhang, Yang Yu, Xi Wang

    Published 2025-01-01
    “…With these promising advancements, the application of pancreatic β cell therapy holds the potential to effectively treat T1D and benefit a larger population of T1D patients.…”
    Get full text
    Article
  6. 226

    Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors by Hui Wang, Yi Zhang, Feng Li, Shasha Liu, Shumin Wang, Wenhao Hu, Yue Liang, Chunyi Shen, Yuyu Zhao

    Published 2025-01-01
    “…Furthermore, glucose restriction can contribute to the failure of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors. However, the impact of glucose restriction remains unknown in CAR-T cell therapy.Methods Glucose transporters were detected and overexpressed in CAR-T cells. …”
    Get full text
    Article
  7. 227

    Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis by I Gusti Ngurah Wien Aryana, Febyan, Shianita Limena

    Published 2023-10-01
    “…Background: Osteoarthritis (OA) is a degenerative synovial joint disease with progressive pain and deformity. Stem cell therapy, especially mesenchymal stem cells (MSCs), has revolutionized the treatment of knee OA. …”
    Get full text
    Article
  8. 228

    A Soft Landing Approach for the Centrifugal Microgel Synthesis Process by Badalan, Matei, Adisson, Lucie, Boldron, Arthur, Achard, Jean-Luc, Ghigliotti, Giovanni, Balarac, Guillaume, Bottausci, Frédéric

    Published 2023-02-01
    “…This represents a significant limitation of this technology, since capsule shape regularity is an important requirement for various biomedical applications (e.g. cell therapy implants, drug delivery). In this article we propose and validate experimentally an adaptation of the centrifugal microencapsulation, based on the concept of “soft landing” [1]. …”
    Get full text
    Article
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234

    Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases by Da Yeon Lee, Sung Eun Lee, Do Hyeon Kwon, Saraswathy Nithiyanandam, Mi Ha Lee, Ji Su Hwang, Shaherin Basith, Jung Hwan Ahn, Tae Hwan Shin, Gwang Lee

    Published 2021-01-01
    “…Especially, for neurological disease cell therapy, the deformability of BM-MSCs is particularly important in the brain for the development of microvessels. …”
    Get full text
    Article
  15. 235

    Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure by Yunxia Tang, Qiongshu Li, Fanwei Meng, Xingyu Huang, Chan Li, Xin Zhou, Xiaoping Zeng, Yixin He, Jia Liu, Xiang Hu, Ji-Fan Hu, Tao Li

    Published 2016-01-01
    “…However, the efficacy of this cell therapy in animal studies needs to be significantly improved before it can be translated into clinics. …”
    Get full text
    Article
  16. 236
  17. 237

    Is there health inequity in Europe today? The ‘strange case’ of the application of an European regulation to cartilage repair by Roberto Beretta

    Published 2016-03-01
    “…The application of this regulation in Europe has resulted in differences in the costs of cell therapy for cartilage injuries in Germany compared with the costs in other European countries and in the U.S. …”
    Get full text
    Article
  18. 238

    The History of Cystinosis: Lessons for Clinical Management by Paul Goodyer

    Published 2011-01-01
    “…Major conceptual break-throughs include (a) its discovery in 1903, (b) recognition of the renal Fanconi syndrome, (c) realization that tissue accumulation of cystine reflects a defective channel in the lysosomal membrane, (d) translation of this discovery to trials of cysteamine, (e) discovery of the CTNS gene, and (f) report of successful stem cell therapy in the cystinotic mouse. This paper focuses on the importance management lessons from these milestones and the potential new therapeutic strategies which may be looming in the near future.…”
    Get full text
    Article
  19. 239
  20. 240

    New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies by Ping Wang, Aitor Aguirre

    Published 2018-01-01
    “…We also summarize the emerging imaging modalities being applied for monitoring anticancer stem cell therapy success and discuss the implications of these novel technologies for precision medicine.…”
    Get full text
    Article